Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

about

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

Item

http://www.wikidata.org/entity/Q47104354

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@en

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@nl

type

Item

label

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@en

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@nl

prefLabel

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@en

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@nl

P1476

Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

@en

P2093

Amin Saburi

http://www.w3.org/2001/XMLSchema#string

Ehsan Saburi

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF

The accuracy of clinicians' predictions of survival in advanced cancer: a review

Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation

The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS.

Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.

Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation

Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.

Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells

Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy.

Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo.

P304

228-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.22088/CJIM.8.4.228

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mostafa Ghanei

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29201312

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5686300

http://www.w3.org/2001/XMLSchema#string